Teicoplanin combined with conventional vancomycin therapy for the treatment of pulmonary methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis infections

doi:10.12998/wjcc.v9.i34.10549

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 34

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3629)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

204

WORD

104

HTML

1983

Tables (1-4)

293

Sum=2584

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

334

Download

711

Sum=1045

Dec 6, 2021 (publication date) through Feb 1, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Dec 6, 2021; 9(34): 10549-10556
Published online Dec 6, 2021. doi: 10.12998/wjcc.v9.i34.10549

Table 2 Treatment effects for patients treated with vancomycin (only) or vancomycin and teicoplanin, n (%)

Group	Number of cases	Markedly effective	Effective	Ineffective	Total efficiency
Study group	43	26 (60.47)	14 (32.56)	3 (6.98)	40 (93.02)
Control group	43	18 (41.86)	15 (34.88)	10 (23.26)	33 (76.74)
χ²value					4.441
P value					0.035

Citation: Wu W, Liu M, Geng JJ, Wang M. Teicoplanin combined with conventional vancomycin therapy for the treatment of pulmonary methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis infections. World J Clin Cases 2021; 9(34): 10549-10556
URL: https://www.wjgnet.com/2307-8960/full/v9/i34/10549.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i34.10549